21 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
between SGLT-2 inhibitors ... (Steglatro) #diabetes ... renal #SGLT2i #Inhibitors ... #pharmacology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... Amaryl), Glyburide (Diabeta ... CARB ABSORPTION INHIBITOR ... Hypoglycemics #Diabetes ... #Management #pharmacology
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
classes of type-2 diabetes ... Loss + - SGLT-2 inhibitors ... Loss +++ - DPP-4 inhibitors ... Weight Gain ++++ #diabetes ... weightgain #comparison #pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... • Euglycemic diabetic ... #Pharmacology # ... Summary #DM2 #diabetes
Clopidogrel (Plavix) and Clopidogrel Non-responders

Clopidogrel is an irreversible selective inhibitor of the platelet low-sensitivity adenosine diphosphate
irreversible selective inhibitor ... strong CYP2C19 inhibitors ... Nonresponders #pharmacology ... #toxicology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... Mechanisms of Action: Inhibits ... #Pharmacology # ... Summary #DM2 #diabetes
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... class of anti-diabetic ... #Pharmacology # ... Medications #DM2 #Diabetes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD, DPP-4 inhibitor ... α-glucosidase inhibitor ... insulin in Type 1 Diabetes ... #Medications #pharmacology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... Stimulates Insulin, Inhibits ... ) 5 mg DPP4 inhibitors ... Renal #Dosing #Pharmacology ... #Management #Diabetes
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Indications and Pharmacology ... Pharmacokinetics: • MOA ... : Inhibits plasminogen ... activation to plasmin & inhibits ... #Indications #Pharmacology